MnM Healthcare

  The market is segmented on the basis of product, testing site, patient care setting, application, and region. Based on product, the market is segmented into self-monitoring blood glucose systems and continuous glucose monitoring systems. The continuous glucose monitoring system segment is expected to grow at the highest CAGR during the forecast period. [181 Pages Report]  The  global blood glucose monitoring system market  was valued at USD 8.10 Billion in 2016 and is projected to reach USD 10.58 Billion by 2022, at a CAGR of 4.8% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the market. Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14912252 The market is segmented on the basis of product, testing site, patient care setting, application, and r

  The growth in this market is driven by the increasing adoption of GC-MS, rising crude & shale oil production, increasing importance of wastewater treatment, rising food safety concerns, and growing use of chromatography tests in the drug approval process. However, the high cost of GC equipment, geopolitical issues prevailing in some countries, and shortage of skilled professionals are expected to restrain the growth of this market during the forecast period. What the Market Looks Like? The  global GC market  size is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.1%.  North America is expected to account for the largest share of the global GC market. The Oil and Gas industry is growing at a CAGR of 4.1% in the end user market of GC. The growth is mainly attributed toincreasing crude & shale oil production and improved gas chromatography columns for the petroleum industry Download PDF Brochure @    https://www.marketsandmarkets.com/pdfdo